AOB - American Oriental Bioengineering Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AOB - American Oriental Bioengineering Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: OmertaSoldier	11/9/2005 11:24:21 AM
	of 47

American Oriental Bioengineering Inc. Applies for Dual Listing on the Archipelago Exchange Wednesday November 9, 8:30 am ET HONG KONG--(BUSINESS WIRE)--Nov. 9, 2005--American Oriental Bioengineering Inc. (AMEX: AOB - News), an emerging Chinese company that produces and distributes a broad range of pharmaceutical and nutraceutical products, announced today that it has applied for the dual listing of its common stock on the Archipelago Exchange (ArcaEx), a facility of the Pacific Exchange. The company's common stock will not begin trading on the ArcaEx until the company has been approved by the Pacific Stock Exchange and satisfied applicable regulatory requirements. The listing of the company's common stock on ArcaEx is subject to the company being in compliance with all applicable listing standards on the date its common stock begins trading on the exchange. The company's common stock is currently listed on the American Stock Exchange under the symbol "AOB." About American Oriental Bioengineering Inc. American Oriental Bioengineering Inc. (AOBO) is a leading Chinese biotechnology company that uses proprietary processes for producing soybean protein peptide more efficiently than traditional extracting techniques. These techniques are used to manufacture and formulate supplemental and medicinal products. Soybean peptides are used widely in general food, health food products and medicines, among other applications. The company also produces Cease-Enuresis Soft Gel, the only Chinese FDA-approved first grade, prescription medicine that is specially formulated to help alleviate bed-wetting and incontinence. The company is a leading producer of products in both the nutraceuticals and pharmaceuticals areas in China. For more information, visit bioaobo.com.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next